Albany, New York, April 29, 2019: The ever growing burden of critical medical conditions and diverse unmet medical needs have significantly prompted fast-paced drug development ventures across pharmaceutical vertical. To efficiently develop and test the efficacy of various drug molecules, availability of robust, high performing mammalian cell lines remain integral.
Owing to such pressing needs for superlative drug development processes, cell line development has experienced large scale adoption to expedite biologics production, carry out high end studies pertaining gene functions, as well as drug development. Adoption of automated processes to accelerate cell line development is a significantly new trend and is likely to augment magnanimous growth in cell line development market in the coming years. A new business intelligence report by Market Research Reports Search Engine (MRRSE) under the title, ‘Cell Line Development Market: Global Industry Analysis 2013-2017 and Opportunity Assessment 2018-2028‘ houses intricate details about new market developments and their reciprocal implications on holistic market growth route.
Cell Line Development Finds Ample Usability in Immunotherapy Development for Cancer
The advantages of cell line development in drug formulation and toxicity testing are many. Besides ensuring high performance results, cell line development significantly ensures minimal time and resource investment, thereby streamlining operational costs. The process is highly beneficial for producing various antibodies besides offering optimum results for immunotherapy treatment for cancer. Guided by the principle of low minimal operational costs and increased throughput, cell line development is witnessing fast transitions into automated process development for superlative outcome.
Cell line development has over the years been plagued by conventional, repetitive manual processing with limited results and low throughput, often susceptible to human error. To offset such prevalent pitfalls, automation of cell line development has emerged as significant milestone. Automated cell culture platform for manufacturing protein therapeutics under controlled conditions has gained tremendous momentum.
Selexis SA and Berkeley Lights Collaborate to Develop Novel Cell Line Development Platform
First line market participants in cell line development space are akin on entering into strategic collaborations and acquisition deals to diversify their offerings. A recent acquisition deal between Selexis SA and Berkeley Lights allows the acquisition of Beacon optofluidic platform of Berkeley Lights. The participating companies envision to tangibly accelerate cell line development with Selexis’ SURE technology. This integrated optofluidic platform and technology are expected to speed up clone identification, thereby ensuring high speed cell line development. Developments as such are poised to further leverage growth in automated cell line development.
North America to Remain Atop in Cell Line Development Market
Thorough research postulates articulated in the report allow readers to gauge at significant market segments comprising product type, source type, type of cell lines and end-user. By source cell line development market is classified into mammalian and non-mammalian cell line. BY product the market is diversified into reagent and media, equipment, and accessories. Biotech companies, CROs, and academics and research institutes comprise prominent end-user segment. IN terms of type, cell line development market is diversified into hybridomas, recombinant cell lines, primary cell lines, and continuous cell lines. On the basis of geographical stratification, the market is demarcated into Europe, North and Latin America, CIS and Russia, APACEJ, MEA, and Japan. Further, the report also sheds light on vendor landscape, highlighting potential growth strategies embraced by lead players to sustain stiffening competition.
Browse Full Cell Line Development Market Report with https://www.mrrse.com/cell-line-development-market
Market Research Reports Search Engine (MRRSE) is an industry-leading database of market intelligence reports. MRRSE is driven by a stellar team of research experts and advisors trained to offer objective advice. Our sophisticated search algorithm returns results based on the report title, geographical region, publisher, or other keywords.
MRRSE partners exclusively with leading global publishers to provide clients single-point access to top-of-the-line market research. MRRSE’s repository is updated every day to keep its clients ahead of the next new trend in market research, be it competitive intelligence, product or service trends or strategic consulting.
90, State Street
Albany, NY – 12207